TUSTIN, Calif., Sept. 30 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. , a leading vertically integrated bio-pharmaceutical company with major operations in China and the US, announced today at its annual meeting of shareholders that is has re-elected the existing members of its Board of Directors, including Dr. Bill Thompson, Dr. Edward Arquilla, Mr. Henry Jai, Mr. Gary Dreher and Mr. Doug MacLellan to the Company’s Board of Directors for the fiscal year 2008.
Long-time board member Dr. Bill Thompson is retiring from his position as Chairman of the Board of the Directors and will assume responsibilities as Chairman of the Governance Committee. Mr. Douglas MacLellan has been appointed AMDL’s new Chairman of the Board serving as the Company’s lead spokesperson and support resource to AMDL’s executive management team. Mr. MacLellan will continue serving as Chairman of the Audit Committee. Dr. Arquilla has been newly appointed as Chairman of the Compensation Committee. There have been no changes to the Company’s executive management team.
About AMDL:
Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The Company has an additional 4 pharmaceutical and diagnostic products under review by various regulatory authorities.
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties related to the Company’s access to additional capital, competition and dependence on key management.
CONTACT: Kristine Szarkowitz, Director, Investor Relations of AMDL, Inc.,
+1-206-310-5323, kszarkowitz@amdl.com
Web site: http://www.amdl.com/
